Evaluation of the Efficacy of Outer Membrane Protein 31 Vaccine Formulations for Protection against Brucella canis in BALB/c Mice
Open Access
- 22 October 2014
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 21 (12) , 1689-1694
Abstract
Canine brucellosis is an infectious disease caused by the Gram-negative bacteriumBrucella canis. Unlike conventional control programs for other species of the genusBrucella, currently there is no vaccine available against canine brucellosis, and preventive measures are simply diagnosis and isolation of infected dogs. New approaches are therefore needed to develop an effective and safe immunization strategy against this zoonotic pathogen. In this study, BALB/c mice were subcutaneously immunized with the following: (i) the recombinantBrucellaOmp31 antigen formulated in different adjuvants (incomplete Freund adjuvant, aluminum hydroxide, Quil A, and Montanide IMS 3012 VGPR), (ii) plasmid pCIOmp31, or (iii) pCIOmp31 plasmid followed by boosting with recombinant Omp31 (rOmp31). The immune response and the protective efficacy againstB. canisinfection were characterized. The different strategies induced a strong immunoglobulin G (IgG) response. Furthermore, spleen cells from rOmp31-immunized mice produced gamma interferon and interleukin-4 (IL-4) afterin vitrostimulation with rOmp31, indicating the induction of a mixed Th1-Th2 response. Recombinant Omp31 administered with different adjuvants as well as the prime-boost strategy conferred protection againstB. canis. In conclusion, our results suggest that Omp31 could be a useful candidate for the development of a subcellular vaccine againstB. canisinfection.Keywords
This publication has 33 references indexed in Scilit:
- HumanBrucella canisoutbreak linked to infection in dogsEpidemiology and Infection, 2009
- Comparison of agar gel immunodiffusion test, rapid slide agglutination test, microbiological culture and PCR for the diagnosis of canine brucellosisResearch in Veterinary Science, 2009
- Role of the Omp25/Omp31 Family in Outer Membrane Properties and Virulence ofBrucella ovisInfection and Immunity, 2007
- Improved Immunogenicity of a Vaccination Regimen Combining a DNA Vaccine Encoding Brucella melitensis Outer Membrane Protein 31 (Omp31) and Recombinant Omp31 BoostingClinical and Vaccine Immunology, 2007
- Current Status of Veterinary VaccinesClinical Microbiology Reviews, 2007
- Vaccination with the RecombinantBrucellaOuter Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+T Helper 1 Response That Protects againstBrucella melitensisInfectionInfection and Immunity, 2005
- A DNA Vaccine Coding for theBrucellaOuter Membrane Protein 31 Confers Protection againstB. melitensisandB. ovisInfection by Eliciting a Specific Cytotoxic ResponseInfection and Immunity, 2005
- Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovisVeterinary Microbiology, 2004
- Antibody Reactivity to Omp31 fromBrucella melitensisin Human and Animal Infections by Smooth and Rough BrucellaeClinical and Vaccine Immunology, 2004
- Minor Nucleotide Substitutions in the omp31 Gene of Brucella ovis Result in Antigenic Differences in the Major Outer Membrane Protein That It Encodes Compared to Those of the Other Brucella SpeciesInfection and Immunity, 2001